These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinically significant drug-drug interaction between tacrolimus and fluconazole in stable renal transplant recipient and literature review. He J; Yu Y; Yin C; Liu H; Zou H; Ma J; Yang W; Liu Y; Zhong L; Chen X J Clin Pharm Ther; 2020 Apr; 45(2):264-269. PubMed ID: 31756280 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients. Lumlertgul D; Noppakun K; Rojanasthien N; Kanchanarattanakorn K; Jittikanont S; Manoyot A; Bunnachak D; Ophascharoensuk V J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S73-8. PubMed ID: 17044457 [TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetic estimation of tacrolimus apparent clearance in adult liver transplant recipients. Zahir H; McLachlan AJ; Nelson A; McCaughan G; Gleeson M; Akhlaghi F Ther Drug Monit; 2005 Aug; 27(4):422-30. PubMed ID: 16044097 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients. Osowski CL; Dix SP; Lin LS; Mullins RE; Geller RB; Wingard JR Transplantation; 1996 Apr; 61(8):1268-72. PubMed ID: 8610430 [TBL] [Abstract][Full Text] [Related]
6. Effect of fluconazole on the pharmacokinetics of everolimus and tacrolimus in a heart transplant recipient: Case report. Nakagita K; Wada K; Terada Y; Matsuda S; Terakawa N; Oita A; Takada M Int J Clin Pharmacol Ther; 2018 Jun; 56(6):270-276. PubMed ID: 29648533 [TBL] [Abstract][Full Text] [Related]
7. Influence of donor-recipient CYP3A4/5 genotypes, age and fluconazole on tacrolimus pharmacokinetics in pediatric liver transplantation: a population approach. Guy-Viterbo V; Baudet H; Elens L; Haufroid V; Lacaille F; Girard M; Debray D; Chardot C; Reding R; Wallemacq P; Musuamba F Pharmacogenomics; 2014 Jun; 15(9):1207-21. PubMed ID: 25141896 [TBL] [Abstract][Full Text] [Related]
8. Tacrolimus: a further update of its use in the management of organ transplantation. Scott LJ; McKeage K; Keam SJ; Plosker GL Drugs; 2003; 63(12):1247-97. PubMed ID: 12790696 [TBL] [Abstract][Full Text] [Related]
9. Drug-Drug Interaction between Tacrolimus and Fluconazole in a Kidney Transplant Recipient. Ferchichi K; Ben Hammamia S; Ben Sassi M; El Jebari H; Charfi R; Daghfous R; Gaies E; Trabelsi S Exp Clin Transplant; 2024 Jan; 22(Suppl 1):356-357. PubMed ID: 38385427 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic drug monitoring of tacrolimus in liver transplantation, phase III FK506 multicenter Spanish Study Group: a two-year follow-up. Pou L; Brunet M; Bilbao I; Andreu H; Andres I; Lopez R; Margarit C; Rimola A; Corbella J Ther Drug Monit; 1998 Dec; 20(6):602-6. PubMed ID: 9853973 [TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients. Sam WJ; Tham LS; Holmes MJ; Aw M; Quak SH; Lee KH; Lim SG; Prabhakaran K; Chan SY; Ho PC Clin Pharmacokinet; 2006; 45(1):59-75. PubMed ID: 16430311 [TBL] [Abstract][Full Text] [Related]
12. Greater impact of oral fluconazole on drug interaction with intravenous calcineurin inhibitors as compared with intravenous fluconazole. Mihara A; Mori T; Aisa Y; Yamazaki R; Iketani O; Tanigawara Y; Ikeda Y; Okamoto S Eur J Clin Pharmacol; 2008 Jan; 64(1):89-91. PubMed ID: 17965855 [TBL] [Abstract][Full Text] [Related]